Glycosaminoglycan-interacting small molecule (gismo) as parkinson's therapeutic
Ended Project Grant Awarded Last action
- Award ID
- R43NS097105
- Recipient
-
Gismo Therapeutics Inc. UEI SY29WJMD4E85
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $384,126
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date
- Originally
- Place of performance
- New York, NY, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $142,188 | |
| Original award | $241,938 |
Quick answers
Who received award R43NS097105?
R43NS097105 was awarded to Gismo Therapeutics Inc. by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on August 1, 2016.
How much is award R43NS097105 worth?
$384,126 has been obligated on R43NS097105.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award